The Patent Finder

Laboratorios Silanes S.A. de C.V.

8 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

3
Ending by 2030
Apr 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Oct 9, 2027
    The maintenance fee for Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same (US 11,951,081) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,287,860Immunogen and antivenom against violin spider venom
In force
 · USPTO record
In forceUSPTO record
US 9,399,677VHNAR anti-cytokine domains
In force
 · USPTO record
In forceUSPTO record
US 9,683,035Polynucleotides encoding VHNAR anti-cytokine domains
In force
 · USPTO record
In forceUSPTO record
US 11,510,886Metformin amino acid compounds and methods of using the same
In force
 · USPTO record
In forceUSPTO record
US 11,155,612vNAR antibody which binds VEGF for use in dogs or cats
In force
 · USPTO record
In forceUSPTO record
US 11,951,081Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
In force
 · USPTO record
In forceUSPTO record
US 12,653,798Fixed Combination Medicine for the Control and Management of Neuropathic Pain
In force
 · High confidence
In forceHigh confidence
US 12,751,958Combination Drug for the Control and Management of Type 2 Diabetes Mellitus
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 8: 4 lapsed for an unpaid fee · 2 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited